[HTML][HTML] Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China

G Song, G Liang, W Liu - Mycopathologia, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been sweeping across the globe. Based on a …

Mucormycosis

G Reid, JP Lynch III, MC Fishbein… - Seminars in respiratory …, 2020 - thieme-connect.com
Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome

ZK Mekonnen, DC Ashraf, T Jankowski… - Ophthalmic Plastic & …, 2021 - journals.lww.com
Acute invasive fungal rhinosinusitis is a rare, although highly morbid, infection primarily
affecting immunosuppressed individuals. The same population is at particularly high risk of …

ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries

SM Rudramurthy, M Hoenigl, JF Meis, OA Cornely… - Mycoses, 2021 - Wiley Online Library
Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

[HTML][HTML] A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India

A Patel, H Kaur, I Xess, JS Michael, J Savio… - Clinical microbiology …, 2020 - Elsevier
Objectives To describe the epidemiology, management and outcome of individuals with
mucormycosis; and to evaluate the risk factors associated with mortality. Methods We …

[HTML][HTML] Pseudomonas indica-Mediated Silver Nanoparticles: Antifungal and Antioxidant Biogenic Tool for Suppressing Mucormycosis Fungi

SS Salem, OM Ali, AM Reyad, KA Abd-Elsalam… - Journal of Fungi, 2022 - mdpi.com
Mucormycosis is considered one of the most dangerous invasive fungal diseases. In this
study, a facile, green and eco-friendly method was used to biosynthesize silver …

Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial

L Millon, D Caillot, A Berceanu… - Clinical Infectious …, 2022 - academic.oup.com
Background Early diagnosis and prompt initiation of specific antifungal treatment are
essential for improving the prognosis of mucormycosis. We aimed to assess the …

[HTML][HTML] Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study …

V Muthu, R Agarwal, A Patel, S Kathirvel… - The Lancet Infectious …, 2022 - thelancet.com
Summary COVID-19-associated pulmonary mucormycosis (CAPM) remains an
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …

A global view on fungal infections in humans and animals: opportunistic infections and microsporidioses

S Gnat, D Łagowski, A Nowakiewicz… - Journal of Applied …, 2021 - academic.oup.com
After cardiovascular diseases, infectious diseases are the second most common cause of
death worldwide. Although these infections are caused mainly by viruses or bacteria, a …

Mucormycosis treatment: Recommendations, latest advances, and perspectives

K Brunet, B Rammaert - Journal de mycologie medicale, 2020 - Elsevier
Mucormycosis are life-threatening fungal infections especially affecting
immunocompromised or diabetic patients. Despite treatment, mortality remains high (from 32 …